Spironolactone

Alternative Names: Aldactone

Spironolactone is a potassium-sparing diuretic and aldosterone antagonist used as an add-on therapy for heart failure with reduced ejection fraction (HFrEF), particularly in patients with persistent symptoms (NYHA class II–IV) despite standard treatment. It works by blocking aldosterone, which helps reduce sodium and water retention, prevent cardiac remodeling, and improve survival. Spironolactone has been shown to lower mortality and hospital.

Treatment Type: Prescription Medication

Treatment Class: N/A

Treatment Modality: N/A

Review Summary

5.0

1 Reviews

Preferred by 1 Reviewers

Based on the review, Spironolactone appears to be an effective treatment for Congestive Heart Failure, particularly for patients with reduced ejection fraction. The medication has been shown to reduce mortality and hospitalization rates, though it requires careful monitoring for potential side effects like hyperkalemia and renal function changes.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
0
1 = Very Expensive 5 = Very Affordable

0

Very Expensive
Relief Speed
0
1 = No Relief 5 = Immediate Relief

0

No Relief
Side Effects
0
1 = Intolerable Effect 5 = No Effect

0

Intolerable Effect
Treatment Line
0
1 = Third-line or more 5 = First-line

0

Third-line or more

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

5.0

1 Reviews
5
100%
4
0%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the review, Spironolactone appears to be an effective treatment for Congestive Heart Failure, particularly for patients with reduced ejection fraction. The medication has been shown to reduce mortality and hospitalization rates, though it requires careful monitoring for potential side effects like hyperkalemia and renal function changes.

Reviews

Filter by reviewer type Pro

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
11 months ago
Spironolactone is a potassium-sparing diuretic commonly used for heart failure with reduced ejection fraction (HFrEF), particularly in patients with persistent symptoms despite ACE inhibitors and beta blockers. It has been shown to reduce mortality and hospitalization, but requires monitoring for hyperkalemia and renal function. It is generally low-cost, with generic versions widely available.